Minority-Patient Derived Xenograft (PDX) Development and Trial Center (PDTC) Network (U54)

Funding Opportunity RFA-CA-17-032 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) solicits applications for Minority PDX (minority patient-derived xenografts) Development and Trial Centers (M-PDTCs). The M-PDTCs will join the PDTC Research Network (PDXNet) and be focused upon development and pre-clinical testing of models derived from racial/ethnic minority populations. The PDXNet is a National Cancer Institute (NCI) program established to coordinate collaborative, large-scale model development and pre-clinical testing of targeted therapeutic agents to advance the vision of cancer precision medicine.
Pub Date: 
Thursday, October 12, 2017 - 11:38pm
Funding Agency: 
NIH